Equillium, Inc. (EQ)
NASDAQ: EQ · Real-Time Price · USD
1.750
-0.180 (-9.33%)
Sep 23, 2026, 10:43 AM EDT - Market open
Equillium Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
15
Market Cap
110.96M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 41.10M | 5.01M | 13.89% |
| Dec 31, 2023 | 36.08M | 20.33M | 128.97% |
| Dec 31, 2022 | 15.76M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
EQ News
- 7 days ago - Equillium to Participate in Stifel's 2026 Virtual Immunology and Inflammation Forum - GlobeNewsWire
- 14 days ago - Equillium Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 18 days ago - Equillium management to meet with Piper Sandler - TheFly
- 21 days ago - Equillium to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 5 weeks ago - Equillium reports Q2 EPS (4c), consensus (6c) - TheFly
- 5 weeks ago - Equillium Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 5 weeks ago - Equillium Earnings release: Q2 2026 - Filings
- 5 weeks ago - Equillium Quarterly report: Q2 2026 - Filings